American tegumentary leishmaniasis in older adults: 44 Cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil

Journal of the American Geriatrics Society

Volumn 58, Issue 3, 2010, Pages 614-616

  De Camargo Ferreira E Vasconcellos, Érica ^a   De Oliveira Schubach, Armando ^a,b   Valete Rosalino, Cláudia Maria ^a,c   De Souza Coutinho, Renata ^a   Conceição Silva, Fátima ^d   De Matos Salgueiro, Mariza ^a   Rosandiski Lyra, Marcelo ^a   Soares Moreira, João ^a   Azeredo Coutinho, Rilza Beatriz ^a,d   Fernandes Pimentel, Maria Inês ^a   Roberto Mortari, Sergio ^e   De Fátima Madeira, Maria ^a   Pereira Quintella, Leonardo ^a   Baptista, Cibele ^a   De Almeida Marzochi, Mauro Célio ^a,b  

^a Funda??o Oswaldo Cruz   (Brazil)

^b Ministério de Ciência Tecnologia e Inovação Salvador   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e CENTRO UNIVERSITÁRIO FRANCISCANO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; MEGALUMINE ANTIMONATE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMERICAN TEGUMENTARY LEISHMANIASIS; ANEMIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAZIL; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAM; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; LETTER; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOPENIA; LOW DRUG DOSE; PARASITE ISOLATION; REPEATED DRUG DOSE; SIDE EFFECT; SKIN DISEASE; SKIN EXAMINATION; SKIN LEISHMANIASIS; SKIN ULCER; THROMBOCYTOPENIA; TREATMENT INDICATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UREA BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPROTOZOAL AGENTS; BRAZIL; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS;

EID: 77949350029     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02747.x     Document Type: Letter

References (10)

1. Marzochi MAC, Marzochi KBF. Tegumentary and visceral leishmaniasis in Brazil. Emerging anthropozoonosis and possibilities for their control. Cadernos Saúde Públ 1994;10(Suppl. 2):359-375.
2. Franke ED, Wignall FS, Cruz ME et al. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 1990;113:934-940.
3. Aronson NE, Wortmann GW, Johnson SC et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: Recent U.S. military experience. Clin Infect Dis 1998;27:1457-1464.
4. Ribeiro AL, Drummond JB, Volpini AC et al. Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine. Braz J Med Biol Res 1999;32:297-301.
5. Deps PD, Viana MC, Falqueto A et al. [Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis]. Rev Soc Bras Med Trop 2000;33:535-543.
6. Saldanha AC, Romero GA, Guerra C et al. [Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity]. Rev Soc Bras Med Trop 2000;33:383-388.
7. Carvalho JAM, Garcia RA. [The aging process in the Brazilian population: A demographic approach]. Cadernos Saúde Públ 2003;19:725-733.
8. Rozenfeld S. [Prevalence, associated factors, and misuse of medication in the elderly: A review]. Cadernos Saúde Públ 2003;19:717-724.
9. Lima-Costa MF, Barreto SM, Giatti L. [Health status, physical functioning, health services utilization, and expenditures on medicines among Brazilian elderly: A descriptive study using data from the National Household Survey]. Cadernos Saúde Públ 2003;19:735-743.
10. Lyons LW, Johnston CB, Covinsky KE et al. Geriatric medicine. In: Tierney LM, McPhee SJ, Papadakis MA, editors. Current Medical Diagnosis & Treatment, 40th Ed. New York: McGraw-Hill, 2001, pp 44-61.